文献速递泌尿生殖腹部MR

前列腺DWI外周带病灶形态分析:与根治性前列腺切除术后组织病理学结果的相关性

Shape Analysis of Peripheral Zone Observations on Prostate DWI: Correlation to Histopathology Outcomes After Radical Prostatectomy.
PubMed 文献 · AJR Am J Roentgenol · 2020-03-31

回顾性分析241例连续接受3-T MRI(含DWI)后行根治性前列腺切除术的外周带主导前列腺癌患者,由两名盲法放射科医师主观判定PI-RADS形态类别并定量分割肿瘤进行形态分析。圆形或椭圆形肿瘤(63.9%)相比新月形(22.8%)和线形或楔形(13.3%)肿瘤具有更高的Gleason评分分级、更高的精囊侵犯率和包膜外侵犯率;定量形态特征「圆形度」和「圆度」与包膜外侵犯、精囊侵犯及Gleason评分升高相关,但组间存在重叠。

要点

  • DWI上外周带肿瘤形态可分为圆形或椭圆形(63.9%)、新月形(22.8%)和线形或楔形(13.3%)。
  • 圆形或椭圆形肿瘤的包膜外侵犯率70.1%、精囊侵犯率26.0%,高于新月形(67.3%、9.1%)和线形或楔形(40.6%、9.4%)。
  • 定量形态特征「圆形度」和「圆度」与包膜外侵犯、精囊侵犯及Gleason评分升高相关,但组间存在重叠。

核心结论

  • DWI上主观判定和定量评估为圆形或椭圆形的的外周带肿瘤与更高的前列腺癌侵袭性相关;约10%的切除外周带肿瘤在DWI上呈线形或楔形。

研究设计与样本

  • 回顾性研究,纳入241例连续的外周带主导前列腺癌男性患者,术前行3-T MRI(含DWI),随后行根治性前列腺切除术;由两名盲法放射科医师评估DWI并判定PI-RADS形态类别及分割肿瘤进行定量形态分析,分歧经共识解决;以Gleason评分和病理分期为参考标准进行比较。

关键影像表现/征象

  • 共识评估结果:63.9%(154/241)肿瘤为圆形或椭圆形,22.8%(55/241)为新月形(即顺应外周带形态),13.3%(32/241)为线形或楔形。
  • 形态评估的观察者间一致性为中等(κ = 0.41)。
  • 圆形或椭圆形肿瘤的Gleason评分分布为GS 6 = 1.3%、GS 7 = 78.0%、GS ≥ 8 = 20.7%,新月形肿瘤为GS 6 = 9.1%、GS 7 = 74.6%、GS ≥ 8 = 16.3%,线形或楔形肿瘤为GS 6 = 6.3%、GS 7 = 78.1%、GS ≥ 8 = 15.6%(p = 0.011)。
  • 圆形或椭圆形肿瘤的包膜外侵犯率和精囊侵犯率分别为70.1%和26.0%,新月形肿瘤为67.3%和9.1%(p = 0.003),线形或楔形肿瘤为40.6%和9.4%(p = 0.008)。
  • 定量形态特征「圆形度」和「圆度」与包膜外侵犯(p < 0.001和p = 0.003)、精囊侵犯(p < 0.001和p = 0.029)及Gleason评分升高(p = 0.009和p = 0.021)相关,但组间存在重叠。

诊断标准与关键数值

  • PI-RADS形态类别包括圆形或椭圆形、新月形(即顺应外周带形态)、线形或楔形。
  • 圆形或椭圆形肿瘤相比新月形和线形或楔形肿瘤,Gleason评分分级更高(p = 0.011)。
  • 圆形或椭圆形肿瘤的包膜外侵犯率和精囊侵犯率高于新月形肿瘤(p = 0.003)和线形或楔形肿瘤(p = 0.008)。
  • 定量形态特征「圆形度」和「圆度」与包膜外侵犯、精囊侵犯及Gleason评分升高相关(p值分别见findings),但组间存在重叠。

临床应用与阅片要点

  • 阅片时可将DWI上外周带肿瘤形态分为圆形或椭圆形、新月形和线形或楔形,圆形或椭圆形形态提示肿瘤侵袭性可能更高。
  • 形态评估的观察者间一致性为中等(κ = 0.41),提示形态判定存在一定主观差异。
  • 定量形态特征「圆形度」和「圆度」与不良病理结果相关,但组间存在重叠,解读时需结合其他影像征象。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The objective of our study was to subjectively and quantitatively assess shape features of peripheral zone (PZ) tumors at DWI compared with pathologic outcomes. MATERIALS AND METHODS. During the study period, 241 consecutive men with PZ dominant prostate tumors underwent 3-T MRI including DWI before undergoing radical prostatectomy. DW images of these patients were retrospectively assessed by two blinded radiologists. The reviewers assigned Prostate Imaging Reporting and Data System (PI-RADS) shape categories (round or oval, crescentic [i.e., conforming to PZ], linear or wedge-shaped) and segmented tumors for quantitative shape analysis. Discrepancies were resolved by consensus. Comparisons were performed with Gleason score (GS) and pathologic stage. RESULTS. Consensus review results were as follows: 63.9% (154/241) of tumors were round or oval; 22.8% (55/241), crescentic; and 13.3% (32/241), linear or wedge-shaped. Agreement for shape assessment was moderate (κ = 0.41). Round or oval tumors were higher grade (GS 6 = 1.3%, GS 7 = 78.0%, GS ≥ 8 = 20.7%) than crescentic tumors (GS 6 = 9.1%, GS 7 = 74.6%, GS ≥ 8 = 16.3%) and linear or wedge-shaped tumors (GS 6 = 6.3%, GS 7 = 78.1%, GS ≥ 8 = 15.6%) (p = 0.011). In addition, round or oval tumors had higher rates of extraprostatic extension (EPE) and seminal vesicle invasion (SVI) (EPE and SVI: 70.1% and 26.0%) than crescentic tumors (67.3% and 9.1%; p = 0.003) and linear or wedge-shaped tumors (40.6% and 9.4%; p = 0.008). Quantitatively, the shape features termed "circularity" and "roundness" were associated with EPE (p < 0.001 and p = 0.003), SVI (p < 0.001 and p = 0.029), and increasing GS (p = 0.009 and p = 0.021), but there was overlap between groups. CONCLUSION. In this study, approximately 10% of resected PZ tumors were linear or wedge-shaped on DWI. PZ tumors that were judged subjectively and evaluated quantitatively to be round or oval were associated with increased prostate cancer aggressiveness.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Abreu-Gomez J, Wu M, McInnes MDF, et al. Shape Analysis of Peripheral Zone Observations on Prostate DWI: Correlation to Histopathology Outcomes After Radical Prostatectomy. AJR Am J Roentgenol. 2020. PMID: 32228325. doi:10.2214/AJR.19.22318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。